Shukra Pharmaceuticals Ltd
BSE:524632
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Shukra Pharmaceuticals Ltd
BSE:524632
|
IN |
|
S
|
Sikri Group ASA
OSE:SIKRI
|
NO |
|
Data#3 Ltd
ASX:DTL
|
AU |
|
Graham Corp
NYSE:GHM
|
US |
|
ALS Ltd
ASX:ALQ
|
AU |
|
Ken Holding Co Ltd
SZSE:300126
|
CN |
|
Home Control International Ltd
HKEX:1747
|
SG |
|
Shenzhen Absen Optoelectronic Co Ltd
SZSE:300389
|
CN |
|
Rattanindia Enterprises Ltd
NSE:RTNINDIA
|
IN |
|
Eleco PLC
LSE:ELCO
|
UK |
|
Leopalace21 Corp
TSE:8848
|
JP |
|
B
|
Bleach Inc
TSE:9162
|
JP |
|
P
|
PhilEnergy Co Ltd
KOSDAQ:378340
|
KR |
|
G
|
Gazprom Neft' PAO
LSE:GAZ
|
RU |
|
Suzumo Machinery Co Ltd
TSE:6405
|
JP |
|
Fujian Star-net Communication Co Ltd
SZSE:002396
|
CN |
|
Immedia Group PLC
LSE:IME
|
UK |
|
Trane Technologies PLC
NYSE:TT
|
IE |
|
C
|
Chai Watana Tannery Group PCL
SET:CWT
|
TH |
|
Stelco Holdings Inc
TSX:STLC
|
CA |
|
M
|
Mitsubishi Chemical Group Corp
F:M3C0
|
JP |
|
Texmaco Infrastructure & Holdings Ltd
NSE:TEXINFRA
|
IN |
|
Pyrum Innovations AG
F:PYR
|
DE |
Bankruptcy Probability
Shukra Pharmaceuticals Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Shukra Pharmaceuticals Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IN |
S
|
Shukra Pharmaceuticals Ltd
BSE:524632
|
15.6B INR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
860.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
213.1B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
286.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
222.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
152.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Shukra Pharmaceuticals Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Shukra Pharmaceuticals Ltd has total debt of 26.8m INR. This includes both short-term (0 INR) and long-term (26.8m INR) debt.
You can find a full breakdown on its Balance Sheet.
